GIVA to raise ₹110 crore in extended series C funding round

Bengaluru-based jewellery brand GIVA is set to raise ₹110 crore in an extended Series C round led by HPV CC1 Ltd, with Premji Invest, Kenro Capital, and Titan Capital participating. The funding, approved via Series C1 CCPS issuance, will support hiring, marketing, and expansion as valuation nears ₹4,900 crore.

Feb 19th, 2026

GIVA to raise ₹110 crore in extended series C funding round

Delhi-based EV startup Pluto Mobility has raised $2 million in a seed round led by Version One Ventures with Grad Capital's participation. Founded by Akshat Bhatia and Himanshu Panda, the startup is developing purpose-built, fully covered electric vehicles for last-mile delivery, with pilot deployments in key urban markets planned for 2026.

Feb 19th, 2026

Pluto Mobility raises $2M to build delivery-focused EVs

French quantum startup Pasqal is reportedly in talks to raise €200 million at a valuation above $1 billion, according to industry reports. The company focuses on neutral-atom quantum technology and aims to scale its processors and software. The funding, if finalised, could strengthen its position against global rivals and support real-world pilots in sectors like pharma and logistics.

Feb 19th, 2026

Pasqal eyes €200 mn raise to scale quantum computing push

Nvidia has set a clear target to enable 500 startups over the next 12 months, signalling a deeper push into the innovation ecosystem. The move highlights the company’s focus on supporting emerging tech-driven ventures at a time when demand for advanced computing infrastructure is rising. The initiative reflects a strategic effort to strengthen long-term engagement with early-stage startups.

Feb 19th, 2026

Nvidia targets 500 startups with new enablement push

A Bengaluru startup unveiled 'Param', a Made-in-India robodog, at the AI Impact Summit, highlighting indigenous innovation. The development gained attention amid controversy over Galgotias University showcasing a Chinese robodog as its own. The contrast sparked debate on authenticity, transparency, and the need to promote genuine technological advancements in India's growing AI ecosystem.

Feb 19th, 2026

Made-in-India 'Param' robodog shines amid AI Summit row

Fei-Fei Li’s startup World Labs has raised $1 billion to build AI that understands the real, physical world. The company is developing "spatial intelligence" models that can see, generate and interact with 3D environments. Backed by Autodesk, Nvidia and AMD, the funding will support applications in robotics, simulation and scientific research.

Feb 19th, 2026

Fei-Fei Li’s World Labs secures $1 billion for spatial AI

Dharini Mudgal

Sukanya Samriddhi Yojana is a government-backed savings scheme for girls. It helps parents save for daughter’s education and marriage. An account can be opened in the girl’s name at any time from birth until she turns 10, with a minimum deposit of ₹250/year. Deposits are allowed for 15 years, after which the account continues to earn interest until it matures.

Feb 19th, 2026

What is the govt-backed 'Sukanya Samriddhi Yojana' for securing a girl's future?

Wedbush's Dan Ives highlighted software, cybersecurity, and infrastructure as key pillars of the AI revolution. He dismissed fears that AI makes software obsolete, calling the "doomsday trade" a ghost. Ives argued that investors risk missing the next wave of tech winners and highlighted Palo Alto Networks as a potential beneficiary, noting that software-led AI spending will accelerate.

Feb 18th, 2026

Dan Ives spotlights software, cybersecurity as AI pillars

ImmunityBio (IBRX) shares jumped 30% after the European Commission granted conditional marketing authorisation for its bladder cancer drug 'Anktiva'. The approval applies to BCG-unresponsive bladder cancer but requires the company to submit further data. The drug is now approved in 33 countries, including the US. Wall Street and retail investors are eyeing further gains.

Feb 18th, 2026

IBRX gains 30% on fresh approval for bladder cancer drug in EU

A five-centre study analysing 1,700-plus DCIS patients aged 55 on average found AI reading pre-surgery mammograms could predict recurrence risk after treatment. Researchers recorded 28 recurrences after breast-conserving surgery and seven after mastectomy. AI scores above 73.5% linked to higher 5- and 10-year recurrence risk, performing on par with existing clinical prediction models.

Feb 18th, 2026

Can AI predict breast cancer returning after surgery?

Popular BizShortz


Recommended Topics

© yugma 2026

Google Play and the Google Play logo are trademarks of Google LLC.

Apple and the Apple logo are trademarks of Apple Inc.